{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:15:00Z","timestamp":1793088900630,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04149-w","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T09:28:17Z","timestamp":1743845297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug-resistant epilepsy in Saudi Arabia: prevalence, predictive factors, and treatment outcomes"],"prefix":"10.1186","volume":"25","author":[{"given":"Meshari","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedaa","family":"Alomari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aser F.","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Albloshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"4149_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eplepsyres.2017.11.015","volume":"139","author":"JJ Falco-Walter","year":"2018","unstructured":"Falco-Walter JJ, Scheffer IE, Fisher RS. The new definition and classification of seizures and epilepsy. Epilepsy Res. 2018;139:73\u20139.","journal-title":"Epilepsy Res"},{"key":"4149_CR2","doi-asserted-by":"crossref","unstructured":"Engel J. Seizures and epilepsy. Oxford University Press, USA; 2013.","DOI":"10.1093\/med\/9780195328547.001.0001"},{"issue":"2","key":"4149_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1684\/epd.2018.0957","volume":"20","author":"MJ Brodie","year":"2018","unstructured":"Brodie MJ, Zuberi SM, Scheffer IE, Fisher RS. The 2017 ILAE classification of seizure types and the epilepsies: what do people with epilepsy and their caregivers need to know? Epileptic Disord. 2018;20(2):77\u201387.","journal-title":"Epileptic Disord"},{"issue":"5","key":"4149_CR4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/epi.16856","volume":"62","author":"A Guekht","year":"2021","unstructured":"Guekht A, Brodie M, Secco M, Li S, Volkers N, Wiebe S. The road to a world health organization global action plan on epilepsy and other neurological disorders. Epilepsia. 2021;62(5):1057\u201363.","journal-title":"Epilepsia"},{"issue":"2","key":"4149_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000522442","volume":"57","author":"A Al Rumayyan","year":"2023","unstructured":"Al Rumayyan A, Alharthi A, Al-Rowaili M, Al-Mehmadi S, Altwaijri W, Alrifai T, et al. The prevalence of active epilepsy in the Kingdom of Saudi Arabia: a cross-sectional study. Neuroepidemiology. 2023;57(2):78\u201389.","journal-title":"Neuroepidemiology"},{"issue":"2","key":"4149_CR6","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.3928\/00904481-20150203-10","volume":"44","author":"R Sankaraneni","year":"2015","unstructured":"Sankaraneni R, Lachhwani D. Antiepileptic drugs\u2014a review. Pediatr Ann. 2015;44(2):e36\u201342.","journal-title":"Pediatr Ann"},{"key":"4149_CR7","doi-asserted-by":"crossref","unstructured":"Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Wiley Online Library; 2010.","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"issue":"1","key":"4149_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","volume":"85","author":"PN Banerjee","year":"2009","unstructured":"Banerjee PN, Filippi D, Hauser WA. The descriptive epidemiology of epilepsy\u2014a review. Epilepsy Res. 2009;85(1):31\u201345.","journal-title":"Epilepsy Res"},{"issue":"17","key":"4149_CR9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0000000000011839","volume":"96","author":"B Sultana","year":"2021","unstructured":"Sultana B, Panzini M-A, Veilleux Carpentier A, Comtois J, Rioux B, Gore G, et al. Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis. Neurology. 2021;96(17):805\u201317.","journal-title":"Neurology"},{"issue":"3","key":"4149_CR10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000515743","volume":"55","author":"M Alshurem","year":"2021","unstructured":"Alshurem M, Aldosari MM, Aljaafari D, Alhashim A, Shariff E, Almatar A, et al. Prevalence of medically resistant epilepsy in Saudi Arabia. Neuroepidemiology. 2021;55(3):232\u20138.","journal-title":"Neuroepidemiology"},{"issue":"12","key":"4149_CR11","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/epi.14596","volume":"59","author":"L Kalilani","year":"2018","unstructured":"Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V. The epidemiology of drug\u2010resistant epilepsy: a systematic review and meta\u2010analysis. Epilepsia. 2018;59(12):2179\u201393.","journal-title":"Epilepsia"},{"issue":"30","key":"4149_CR12","doi-asserted-by":"crossref","first-page":"e16402","DOI":"10.1097\/MD.0000000000016402","volume":"98","author":"W Xue-Ping","year":"2019","unstructured":"Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis. Medicine. 2019;98(30):e16402.","journal-title":"Medicine"},{"key":"4149_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yebeh.2013.09.046","volume":"31","author":"JA Cramer","year":"2014","unstructured":"Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, et al. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Epilepsy Behav. 2014;31:356\u201362.","journal-title":"Epilepsy Behav"},{"key":"4149_CR14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fneur.2017.00712","volume":"8","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese J-P. The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using German health insurance data. Front Neurol. 2017;8:712.","journal-title":"Front Neurol"},{"issue":"18","key":"4149_CR15","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.0b013e318271f77e","volume":"79","author":"R Manjunath","year":"2012","unstructured":"Manjunath R, Paradis PE, Paris\u00e9 H, Lafeuille M-H, Bowers B, Duh MS, et al. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Neurology. 2012;79(18):1908\u201316.","journal-title":"Neurology"},{"issue":"10","key":"4149_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/ene.12203","volume":"20","author":"S Balestrini","year":"2013","unstructured":"Balestrini S, Cagnetti C, Foschi N, Buratti L, Petrelli C, Luzzi S, et al. Emergency room access for recurring seizures: when and why. Eur J Neurol. 2013;20(10):1411\u20136.","journal-title":"Eur J Neurol"},{"key":"4149_CR17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40263-017-0471-7","volume":"31","author":"B Abou-Khalil","year":"2017","unstructured":"Abou-Khalil B. Selecting rational drug combinations in epilepsy. CNS Drugs. 2017;31:835\u201344.","journal-title":"CNS Drugs"},{"issue":"3","key":"4149_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","volume":"75","author":"Z Chen","year":"2018","unstructured":"Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279\u201386.","journal-title":"JAMA Neurol"},{"issue":"20","key":"4149_CR19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","volume":"78","author":"M Brodie","year":"2012","unstructured":"Brodie M, Barry S, Bamagous G, Norrie J, Kwan yP. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78(20):1548\u201354.","journal-title":"Neurology"},{"issue":"4","key":"4149_CR20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1528-1167.2012.03416.x","volume":"53","author":"I Gilioli","year":"2012","unstructured":"Gilioli I, Vignoli A, Visani E, Casazza M, Canafoglia L, Chiesa V, et al. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of new antiepileptic drugs. Epilepsia. 2012;53(4):733\u201340.","journal-title":"Epilepsia"},{"issue":"4","key":"4149_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nrleng.2012.04.013","volume":"28","author":"V Villanueva","year":"2013","unstructured":"Villanueva V, Gir\u00f3n J, Mart\u00edn J, Hern\u00e1ndez-Pastor L, Lahuerta J, Doz M, et al. Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study. Neurolog\u00eda (English Edition). 2013;28(4):195\u2013204.","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"4149_CR22","doi-asserted-by":"crossref","first-page":"107086","DOI":"10.1016\/j.clineuro.2021.107086","volume":"213","author":"P Mohammadzadeh","year":"2022","unstructured":"Mohammadzadeh P, Nazarbaghi S. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy. Clin Neurol Neurosurg. 2022;213:107086.","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"4149_CR23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.eplepsyres.2014.05.005","volume":"108","author":"ST Kong","year":"2014","unstructured":"Kong ST, Ho CS, Ho PC, Lim S-H. Prevalence of drug resistant epilepsy in adults with epilepsy attending a neurology clinic of a tertiary referral hospital in Singapore. Epilepsy Res. 2014;108(7):1253\u201362.","journal-title":"Epilepsy Res"},{"issue":"8","key":"4149_CR24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.seizure.2013.04.010","volume":"22","author":"WM Farghaly","year":"2013","unstructured":"Farghaly WM, El-Tallawy HN, Rageh TA, Mohamed EM, Metwally NA, Shehata GA, et al. Epidemiology of uncontrolled epilepsy in the Al-Kharga district, new Valley, Egypt. Seizure. 2013;22(8):611\u20136.","journal-title":"Seizure"},{"key":"4149_CR25","unstructured":"Younis N, Mohamed M, Alolayan A, Alhussain G, Al-Mousa H, Alshamrani J et al. Identification of epilepsy concomitant candidate genes recognized in Saudi epileptic patients. Eur Rev Med Pharmacol Sci. 2022;26(6)."},{"issue":"8","key":"4149_CR26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/children10081334","volume":"10","author":"FA Bashiri","year":"2023","unstructured":"Bashiri FA, AlSheikh R, Hamad MH, Alsheikh H, Alsheikh RA, Kentab A, et al. Genotype\u2013Phenotype analysis of children with epilepsy referred for Whole-Exome sequencing at a tertiary care university hospital. Children. 2023;10(8):1334.","journal-title":"Children"},{"issue":"1","key":"4149_CR27","first-page":"57","volume":"18","author":"NA Alonazi","year":"2018","unstructured":"Alonazi NA, Alnemri A, El Melegy E, Mohamed N, Talaat I, Hosny A, et al. Clinical characteristics and aetiology of early childhood epilepsy: a single centre experience in Saudi Arabia. Sudan J Paediatrics. 2018;18(1):57.","journal-title":"Sudan J Paediatrics"},{"key":"4149_CR28","doi-asserted-by":"crossref","first-page":"1243518","DOI":"10.3389\/fgene.2023.1243518","volume":"14","author":"AS Alqahtani","year":"2023","unstructured":"Alqahtani AS, Alotibi RS, Aloraini T, Almsned F, Alassali Y, Alfares A, et al. Prospect of genetic disorders in Saudi Arabia. Front Genet. 2023;14:1243518.","journal-title":"Front Genet"},{"key":"4149_CR29","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/epi4.12590","volume":"7","author":"P Campos-Bedolla","year":"2022","unstructured":"Campos-Bedolla P, Feria\u2010Romero I, Orozco\u2010Su\u00e1rez S. Factors not considered in the study of drug\u2010resistant epilepsy: Drug\u2010resistant epilepsy: assessment of neuroinflammation. Epilepsia Open. 2022;7:S68\u201380.","journal-title":"Epilepsia Open"},{"issue":"1","key":"4149_CR30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0887-8994(03)00028-6","volume":"29","author":"KL Kwong","year":"2003","unstructured":"Kwong KL, Sung WY, Wong SN, So KT. Early predictors of medical intractability in childhood epilepsy. Pediatr Neurol. 2003;29(1):46\u201352.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"4149_CR31","first-page":"351","volume":"48","author":"J Singhvi","year":"2000","unstructured":"Singhvi J, Sawhney I, Lal V, Pathak A, Prabhakar S. Profile of intractable epilepsy in a tertiary referral center. Neurol India. 2000;48(4):351\u20136.","journal-title":"Neurol India"},{"issue":"10","key":"4149_CR32","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/03007995.2024.2396049","volume":"40","author":"J Mao","year":"2024","unstructured":"Mao J, Song Y, Cheng M, Xu C, Boca A, Dandurand A, et al. Seizure burden and healthcare resource utilization among people living with drug-resistant focal epilepsy in the united States. Curr Med Res Opin. 2024;40(10):1727\u201336.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"4149_CR33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/epi4.12967","volume":"9","author":"J Mao","year":"2024","unstructured":"Mao J, Takahashi K, Cheng M, Xu C, Boca A, Song Y, et al. Real-world anti\u2010seizure treatment and adverse events among individuals living with drug\u2010resistant focal epilepsy in the united States. Epilepsia Open. 2024;9(4):1311\u201320.","journal-title":"Epilepsia Open"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04149-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T09:28:52Z","timestamp":1743845332000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04149-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4149"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04149-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the King Abdullah International Medical Research Center (KAIMRC) Institutional Review Board (IRB) (NRC23R\/221\/04). This research was carried out in accordance with the Declaration of Helsinki. Waiver of written informed consent was approved by the IRB due to the retrospective design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}